{name}
{subtitle}
Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
city
Nearby (Reims, France, +8 more cities)
facility
Hôpital Robert Debré, +1 more facility
drug
irinotecan, +1 more drug
drug type
chemotherapy, +1 more type
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure
city
Nearby (Reims, France, +7 more cities)
facility
CHU de Reims
drug
lenvatinib, +1 more drug
drug type
Other, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~70 mi. (Saint-Quentin, France, +226 more cities)
facility
C.H. de Saint Quentin ( Site 0481)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~70 mi. (Saint-Quentin, France, +122 more cities)
facility
C.H. de Saint Quentin ( Site 1111)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~98 mi. (Bobigny, France, +158 more cities)
facility
Hopital Avicenne ( Site 0803)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~98 mi. (Bobigny, France, +197 more cities)
facility
Hopital Avicenne - APHP /ID# 215152
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~98 mi. (Bobigny, France, +142 more cities)
facility
Hopital Avicenne - Hématologie Clinique
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~98 mi. (Bobigny, France, +165 more cities)
facility
Hopital Avicenne - APHP /ID# 221286
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug